Our study firstly established a seven-gene signature comprising METTL3, COL18A1, NASP, PHLPP2, TIMP1, U2AF2, and VEGFA with a good capability for predicting survival in glioma. This evidence concerns the gene PHLPP2 and central nervous system cancer.